HENRY SCHEIN INC (HSIC) Fundamental Analysis & Valuation

NASDAQ:HSIC • US8064071025

77.6 USD
-2.57 (-3.21%)
At close: Mar 6, 2026
77.6 USD
0 (0%)
After Hours: 3/6/2026, 8:24:30 PM

This HSIC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

HSIC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of HSIC while its profitability can be described as average. HSIC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. HSIC Profitability Analysis

1.1 Basic Checks

  • In the past year HSIC was profitable.
  • In the past year HSIC had a positive cash flow from operations.
  • HSIC had positive earnings in each of the past 5 years.
  • Each year in the past 5 years HSIC had a positive operating cash flow.
HSIC Yearly Net Income VS EBIT VS OCF VS FCFHSIC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

1.2 Ratios

  • HSIC has a better Return On Assets (3.55%) than 67.33% of its industry peers.
  • The Return On Equity of HSIC (12.27%) is better than 79.21% of its industry peers.
  • The Return On Invested Capital of HSIC (6.61%) is better than 64.36% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HSIC is below the industry average of 9.07%.
Industry RankSector Rank
ROA 3.55%
ROE 12.27%
ROIC 6.61%
ROA(3y)3.77%
ROA(5y)5%
ROE(3y)11.71%
ROE(5y)13.84%
ROIC(3y)6.73%
ROIC(5y)8.18%
HSIC Yearly ROA, ROE, ROICHSIC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • HSIC's Profit Margin of 3.02% is fine compared to the rest of the industry. HSIC outperforms 68.32% of its industry peers.
  • In the last couple of years the Profit Margin of HSIC has declined.
  • HSIC's Operating Margin of 5.79% is fine compared to the rest of the industry. HSIC outperforms 65.35% of its industry peers.
  • In the last couple of years the Operating Margin of HSIC has remained more or less at the same level.
  • HSIC has a Gross Margin of 31.14%. This is comparable to the rest of the industry: HSIC outperforms 59.41% of its industry peers.
  • HSIC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.79%
PM (TTM) 3.02%
GM 31.14%
OM growth 3Y-5.84%
OM growth 5Y0.67%
PM growth 3Y-10.8%
PM growth 5Y-5.44%
GM growth 3Y0.92%
GM growth 5Y2.29%
HSIC Yearly Profit, Operating, Gross MarginsHSIC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

3

2. HSIC Health Analysis

2.1 Basic Checks

  • HSIC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • HSIC has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, HSIC has less shares outstanding
  • Compared to 1 year ago, HSIC has a worse debt to assets ratio.
HSIC Yearly Shares OutstandingHSIC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
HSIC Yearly Total Debt VS Total AssetsHSIC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • HSIC has an Altman-Z score of 2.64. This is not the best score and indicates that HSIC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • HSIC's Altman-Z score of 2.64 is in line compared to the rest of the industry. HSIC outperforms 58.42% of its industry peers.
  • The Debt to FCF ratio of HSIC is 5.96, which is a neutral value as it means it would take HSIC, 5.96 years of fcf income to pay off all of its debts.
  • HSIC has a Debt to FCF ratio (5.96) which is in line with its industry peers.
  • HSIC has a Debt/Equity ratio of 0.95. This is a neutral value indicating HSIC is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.95, HSIC perfoms like the industry average, outperforming 43.56% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 5.96
Altman-Z 2.64
ROIC/WACC0.82
WACC8.03%
HSIC Yearly LT Debt VS Equity VS FCFHSIC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • HSIC has a Current Ratio of 1.38. This is a normal value and indicates that HSIC is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.38, HSIC perfoms like the industry average, outperforming 52.48% of the companies in the same industry.
  • A Quick Ratio of 0.76 indicates that HSIC may have some problems paying its short term obligations.
  • HSIC has a worse Quick ratio (0.76) than 78.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.76
HSIC Yearly Current Assets VS Current LiabilitesHSIC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

4

3. HSIC Growth Analysis

3.1 Past

  • HSIC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.85%.
  • HSIC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.85% yearly.
  • The Revenue has been growing slightly by 4.03% in the past year.
  • Measured over the past years, HSIC shows a small growth in Revenue. The Revenue has been growing by 5.43% on average per year.
EPS 1Y (TTM)4.85%
EPS 3Y1.45%
EPS 5Y10.85%
EPS Q2Q%12.61%
Revenue 1Y (TTM)4.03%
Revenue growth 3Y1.4%
Revenue growth 5Y5.43%
Sales Q2Q%7.71%

3.2 Future

  • HSIC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.69% yearly.
  • HSIC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.97% yearly.
EPS Next Y9.23%
EPS Next 2Y10.16%
EPS Next 3Y9.78%
EPS Next 5Y8.69%
Revenue Next Year4.82%
Revenue Next 2Y4.22%
Revenue Next 3Y4.02%
Revenue Next 5Y3.97%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HSIC Yearly Revenue VS EstimatesHSIC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
HSIC Yearly EPS VS EstimatesHSIC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

6

4. HSIC Valuation Analysis

4.1 Price/Earnings Ratio

  • HSIC is valuated correctly with a Price/Earnings ratio of 15.61.
  • Compared to the rest of the industry, the Price/Earnings ratio of HSIC indicates a rather cheap valuation: HSIC is cheaper than 80.20% of the companies listed in the same industry.
  • HSIC is valuated rather cheaply when we compare the Price/Earnings ratio to 26.29, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 14.29 indicates a correct valuation of HSIC.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HSIC indicates a rather cheap valuation: HSIC is cheaper than 81.19% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.57, HSIC is valued a bit cheaper.
Industry RankSector Rank
PE 15.61
Fwd PE 14.29
HSIC Price Earnings VS Forward Price EarningsHSIC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HSIC indicates a somewhat cheap valuation: HSIC is cheaper than 71.29% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, HSIC is valued a bit cheaper than 68.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.08
EV/EBITDA 10.59
HSIC Per share dataHSIC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of HSIC may justify a higher PE ratio.
PEG (NY)1.69
PEG (5Y)1.44
EPS Next 2Y10.16%
EPS Next 3Y9.78%

0

5. HSIC Dividend Analysis

5.1 Amount

  • No dividends for HSIC!.
Industry RankSector Rank
Dividend Yield 0%

HSIC Fundamentals: All Metrics, Ratios and Statistics

HENRY SCHEIN INC

NASDAQ:HSIC (3/6/2026, 8:24:30 PM)

After market: 77.6 0 (0%)

77.6

-2.57 (-3.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-04
Inst Owners97.45%
Inst Owner Change-4.25%
Ins Owners0.79%
Ins Owner Change-0.73%
Market Cap8.90B
Revenue(TTM)13.18B
Net Income(TTM)398.00M
Analysts73.91
Price Target80.8 (4.12%)
Short Float %4.91%
Short Ratio3.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.42%
Min EPS beat(2)1.07%
Max EPS beat(2)5.78%
EPS beat(4)3
Avg EPS beat(4)-0.28%
Min EPS beat(4)-9.54%
Max EPS beat(4)5.78%
EPS beat(8)5
Avg EPS beat(8)0.41%
EPS beat(12)6
Avg EPS beat(12)-0.67%
EPS beat(16)7
Avg EPS beat(16)-0.67%
Revenue beat(2)1
Avg Revenue beat(2)0.29%
Min Revenue beat(2)-0.09%
Max Revenue beat(2)0.67%
Revenue beat(4)1
Avg Revenue beat(4)-1.15%
Min Revenue beat(4)-3.77%
Max Revenue beat(4)0.67%
Revenue beat(8)1
Avg Revenue beat(8)-2.81%
Revenue beat(12)1
Avg Revenue beat(12)-2.86%
Revenue beat(16)1
Avg Revenue beat(16)-2.9%
PT rev (1m)1.89%
PT rev (3m)2.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.11%
EPS NY rev (1m)0%
EPS NY rev (3m)1.98%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.15%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 15.61
Fwd PE 14.29
P/S 0.68
P/FCF 17.08
P/OCF 12.5
P/B 2.74
P/tB N/A
EV/EBITDA 10.59
EPS(TTM)4.97
EY6.4%
EPS(NY)5.43
Fwd EY7%
FCF(TTM)4.54
FCFY5.85%
OCF(TTM)6.21
OCFY8%
SpS114.94
BVpS28.29
TBVpS-17.31
PEG (NY)1.69
PEG (5Y)1.44
Graham Number56.25
Profitability
Industry RankSector Rank
ROA 3.55%
ROE 12.27%
ROCE 9.57%
ROIC 6.61%
ROICexc 6.73%
ROICexgc 17.19%
OM 5.79%
PM (TTM) 3.02%
GM 31.14%
FCFM 3.95%
ROA(3y)3.77%
ROA(5y)5%
ROE(3y)11.71%
ROE(5y)13.84%
ROIC(3y)6.73%
ROIC(5y)8.18%
ROICexc(3y)6.85%
ROICexc(5y)8.33%
ROICexgc(3y)17.53%
ROICexgc(5y)20.16%
ROCE(3y)9.53%
ROCE(5y)11.26%
ROICexgc growth 3Y-9.25%
ROICexgc growth 5Y-2.87%
ROICexc growth 3Y-13.61%
ROICexc growth 5Y-4.22%
OM growth 3Y-5.84%
OM growth 5Y0.67%
PM growth 3Y-10.8%
PM growth 5Y-5.44%
GM growth 3Y0.92%
GM growth 5Y2.29%
F-Score4
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 5.96
Debt/EBITDA 2.86
Cap/Depr 61.41%
Cap/Sales 1.45%
Interest Coverage 5.06
Cash Conversion 66.23%
Profit Quality 130.91%
Current Ratio 1.38
Quick Ratio 0.76
Altman-Z 2.64
F-Score4
WACC8.03%
ROIC/WACC0.82
Cap/Depr(3y)66.59%
Cap/Depr(5y)56.55%
Cap/Sales(3y)1.48%
Cap/Sales(5y)1.17%
Profit Quality(3y)125.21%
Profit Quality(5y)113.92%
High Growth Momentum
Growth
EPS 1Y (TTM)4.85%
EPS 3Y1.45%
EPS 5Y10.85%
EPS Q2Q%12.61%
EPS Next Y9.23%
EPS Next 2Y10.16%
EPS Next 3Y9.78%
EPS Next 5Y8.69%
Revenue 1Y (TTM)4.03%
Revenue growth 3Y1.4%
Revenue growth 5Y5.43%
Sales Q2Q%7.71%
Revenue Next Year4.82%
Revenue Next 2Y4.22%
Revenue Next 3Y4.02%
Revenue Next 5Y3.97%
EBIT growth 1Y3.66%
EBIT growth 3Y-4.53%
EBIT growth 5Y6.15%
EBIT Next Year19.71%
EBIT Next 3Y10.03%
EBIT Next 5YN/A
FCF growth 1Y-21.18%
FCF growth 3Y0.98%
FCF growth 5Y-1.08%
OCF growth 1Y-16.04%
OCF growth 3Y5.75%
OCF growth 5Y3.52%

HENRY SCHEIN INC / HSIC FAQ

What is the ChartMill fundamental rating of HENRY SCHEIN INC (HSIC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to HSIC.


What is the valuation status of HENRY SCHEIN INC (HSIC) stock?

ChartMill assigns a valuation rating of 6 / 10 to HENRY SCHEIN INC (HSIC). This can be considered as Fairly Valued.


Can you provide the profitability details for HENRY SCHEIN INC?

HENRY SCHEIN INC (HSIC) has a profitability rating of 6 / 10.


What are the PE and PB ratios of HENRY SCHEIN INC (HSIC) stock?

The Price/Earnings (PE) ratio for HENRY SCHEIN INC (HSIC) is 15.61 and the Price/Book (PB) ratio is 2.74.


What is the earnings growth outlook for HENRY SCHEIN INC?

The Earnings per Share (EPS) of HENRY SCHEIN INC (HSIC) is expected to grow by 9.23% in the next year.